FDA Investigator

Wayne E Seifert

Latest inspection on record: Bedford, United States, June 2026 · records back to 2015

Human DrugsBiologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 74 inspections across 62 sites are on record.
  • 21 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-10.

At a glance

Inspections

74

Sites

62

Observations

21

Career since

Mar 2015

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Lyophilization Services of New England, Inc. dba PCI Pharma Services10 Jun 2026Human DrugsOn file
ImmunityBio, Inc.1 May 2026Human DrugsOn file
Hospira, Inc.10 Mar 2026Human DrugsOn file
Loba Feinchemie GmbH11 Nov 2025Human DrugsOn file
Amgen Technology (Ireland) Unlimited Company16 Sep 2025Human DrugsOn file

Sites inspected

Lyophilization Services of New England, Inc. dba PCI Pharma ServicesBedford, United States1 insp.
ImmunityBio, Inc.San Diego, United States1 insp.
Hospira, Inc.Mcpherson, United States1 insp.
Loba Feinchemie GmbHFischamend, Austria1 insp.
Amgen Technology (Ireland) Unlimited CompanyDun Laoghaire, Ireland1 insp.

Co-investigators

Investigators who share inspections with this person.

Reyes Candau-Chacon3 shared
Maria J Lopez- Barragan3 shared
Zhihao Pete Qiu3 shared
Virginia A Carroll2 shared
Diane L Raccasi2 shared
Michael Shanks2 shared
Talia A Faison1 shared
Ogechi C Nna1 shared
Daniel L Zheng1 shared

Full investigator report

Get the verbatim findings behind Wayne E Seifert's 21 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators